NASDAQ:MRNS - Marinus Pharmaceuticals News Headlines

Sign in or create an account to add this stock to your watchlist.
$4.21 -0.89 (-17.45 %)
(As of 12/12/2018 04:00 PM ET)
Previous Close$5.10
Today's Range$4.10 - $4.67
52-Week Range$3.31 - $10.54
Volume4.02 million shs
Average Volume905,832 shs
Market Capitalization$209.51 million
P/E Ratio-5.26
Dividend YieldN/A
Beta3.19

Headlines

Marinus Pharmaceuticals (NASDAQ MRNS) News Headlines

Source:
DateHeadline
Marinus Pharmas Postpartum Depression Candidate Aces Midstage Trials (NASDAQ:MRNS) - BenzingaMarinus Pharma's Postpartum Depression Candidate Aces Midstage Trials (NASDAQ:MRNS) - Benzinga
www.benzinga.com - December 12 at 4:12 PM
Teligent leads healthcare gainers; Neurocrine Biosciences and Marinus Pharmaceuticals among losers - Seeking AlphaTeligent leads healthcare gainers; Neurocrine Biosciences and Marinus Pharmaceuticals among losers - Seeking Alpha
seekingalpha.com - December 12 at 4:12 PM
Marinus Pharmaceuticals Announces Positive Ganaxolone Data in Women With Postpartum Depression - GlobeNewswireMarinus Pharmaceuticals Announces Positive Ganaxolone Data in Women With Postpartum Depression - GlobeNewswire
globenewswire.com - December 12 at 4:12 PM
Marinus Pharmaceuticals Announces Public Offering of Common Stock - GlobeNewswireMarinus Pharmaceuticals Announces Public Offering of Common Stock - GlobeNewswire
globenewswire.com - December 12 at 4:12 PM
Marinus Pharmaceuticals (MRNS) Given a $22.00 Price Target by LADENBURG THALM/SH SH AnalystsMarinus Pharmaceuticals (MRNS) Given a $22.00 Price Target by LADENBURG THALM/SH SH Analysts
www.americanbankingnews.com - December 12 at 9:18 AM
Marinus Pharmaceuticals (MRNS) Rating Reiterated by MizuhoMarinus Pharmaceuticals (MRNS) Rating Reiterated by Mizuho
www.americanbankingnews.com - December 11 at 12:07 PM
Marinus Shows Impressive Data In Depression StudiesMarinus Shows Impressive Data In Depression Studies
seekingalpha.com - December 11 at 9:02 AM
Marinus Pharmaceuticals Sees Unusually Large Options Volume (MRNS)Marinus Pharmaceuticals Sees Unusually Large Options Volume (MRNS)
www.americanbankingnews.com - December 11 at 6:40 AM
Marinus Gains on Positive Postpartum ResultsMarinus Gains on Positive Postpartum Results
www.baystreet.ca - December 10 at 5:24 PM
Marinus Scores Big With Midstage Depression StudyMarinus Scores Big With Midstage Depression Study
247wallst.com - December 10 at 5:24 PM
Marinus Pharmas Postpartum Depression Candidate Aces Midstage TrialsMarinus Pharma's Postpartum Depression Candidate Aces Midstage Trials
finance.yahoo.com - December 10 at 5:24 PM
Marinus Pharmaceuticals (MRNS) Price Target Raised to $29.00Marinus Pharmaceuticals (MRNS) Price Target Raised to $29.00
www.americanbankingnews.com - December 10 at 3:26 PM
Cantor Fitzgerald Analysts Give Marinus Pharmaceuticals (MRNS) a $25.00 Price TargetCantor Fitzgerald Analysts Give Marinus Pharmaceuticals (MRNS) a $25.00 Price Target
www.americanbankingnews.com - December 10 at 10:32 AM
Marinus Pharmas ganaxolone shows positive action in mid-stage postpartum depression studies; shares up 35% premarketMarinus Pharma's ganaxolone shows positive action in mid-stage postpartum depression studies; shares up 35% premarket
seekingalpha.com - December 10 at 8:21 AM
Marinus Pharmaceuticals Announces Positive Ganaxolone Data in Women With Postpartum DepressionMarinus Pharmaceuticals Announces Positive Ganaxolone Data in Women With Postpartum Depression
finance.yahoo.com - December 10 at 8:21 AM
Options Traders Expect Huge Moves in Marinus Pharmaceuticals (MRNS) StockOptions Traders Expect Huge Moves in Marinus Pharmaceuticals (MRNS) Stock
www.zacks.com - December 7 at 8:26 AM
Emboldened By Sages Zulresso Slip, Marinus Is Set To Succeed In PPD And Orphan EpilepsyEmboldened By Sage's Zulresso Slip, Marinus Is Set To Succeed In PPD And Orphan Epilepsy
seekingalpha.com - December 5 at 8:25 AM
Marinus Pharmaceuticals Phase 2 clinical trial in pediatric genetic epilepsies shows positive dataMarinus Pharmaceuticals Phase 2 clinical trial in pediatric genetic epilepsies shows positive data
seekingalpha.com - December 4 at 5:32 PM
Marinus Pharmaceuticals (MRNS) Given a $19.00 Price Target at Cantor FitzgeraldMarinus Pharmaceuticals (MRNS) Given a $19.00 Price Target at Cantor Fitzgerald
www.americanbankingnews.com - December 4 at 11:29 AM
Marinus Pharma (MRNS) Phase 2 Data Show L-T Effectiveness of Ganaxolone in Reducing Seizure Frequency in CDKL5 Deficiency Disorder PatientsMarinus Pharma (MRNS) Phase 2 Data Show L-T Effectiveness of Ganaxolone in Reducing Seizure Frequency in CDKL5 Deficiency Disorder Patients
www.streetinsider.com - December 4 at 8:34 AM
Marinus Pharmaceuticals Phase 2 Clinical Trial Data Show Long-term Effectiveness of Ganaxolone in Reducing Seizure Frequency in CDKL5 Deficiency Disorder PatientsMarinus Pharmaceuticals Phase 2 Clinical Trial Data Show Long-term Effectiveness of Ganaxolone in Reducing Seizure Frequency in CDKL5 Deficiency Disorder Patients
finance.yahoo.com - December 4 at 8:34 AM
 Brokerages Expect Marinus Pharmaceuticals Inc (MRNS) Will Announce Earnings of -$0.29 Per Share Brokerages Expect Marinus Pharmaceuticals Inc (MRNS) Will Announce Earnings of -$0.29 Per Share
www.americanbankingnews.com - December 1 at 5:12 PM
Marinus Pharmaceuticals Inc (MRNS) Given Consensus Rating of "Buy" by AnalystsMarinus Pharmaceuticals Inc (MRNS) Given Consensus Rating of "Buy" by Analysts
www.americanbankingnews.com - November 24 at 1:28 AM
Is the Options Market Predicting a Spike in Marinus Pharmaceuticals (MRNS) Stock?Is the Options Market Predicting a Spike in Marinus Pharmaceuticals (MRNS) Stock?
www.zacks.com - November 6 at 8:26 AM
Marinus Pharmaceuticals misses by $0.06Marinus Pharmaceuticals misses by $0.06
seekingalpha.com - October 29 at 8:28 AM
Marinus Pharmaceuticals: 3Q Earnings SnapshotMarinus Pharmaceuticals: 3Q Earnings Snapshot
finance.yahoo.com - October 29 at 8:28 AM
Marinus Pharmaceuticals Provides Business Update and Third Quarter 2018 Financial ResultsMarinus Pharmaceuticals Provides Business Update and Third Quarter 2018 Financial Results
finance.yahoo.com - October 29 at 8:28 AM
Partial Seizure - 2018 Pipeline Insights featuring Eisai, Pfizer, UCB, Marinus Pharma, SciFluor Life Sciences, and SK ...Partial Seizure - 2018 Pipeline Insights featuring Eisai, Pfizer, UCB, Marinus Pharma, SciFluor Life Sciences, and SK ...
www.businesswire.com - October 17 at 4:52 PM
Marinus Pharmaceuticals Names Dr. Rolando Gutíerrez-Esteinou as VP of Clinical Development and PharmacovigilanceMarinus Pharmaceuticals Names Dr. Rolando Gutíerrez-Esteinou as VP of Clinical Development and Pharmacovigilance
finance.yahoo.com - October 10 at 8:25 AM
What Kind Of Shareholders Own Marinus Pharmaceuticals Inc (NASDAQ:MRNS)?What Kind Of Shareholders Own Marinus Pharmaceuticals Inc (NASDAQ:MRNS)?
finance.yahoo.com - September 28 at 4:56 PM
Marinus Completes Enrollment in its Magnolia Postpartum Depression StudyMarinus Completes Enrollment in its Magnolia Postpartum Depression Study
finance.yahoo.com - September 25 at 8:20 AM
Notable Monday Option Activity: MRNS, BA, INSMNotable Monday Option Activity: MRNS, BA, INSM
www.nasdaq.com - September 17 at 5:12 PM
Marinus Appoints Scott Braunstein, MD to its Board of DirectorsMarinus Appoints Scott Braunstein, MD to its Board of Directors
www.nasdaq.com - September 5 at 8:31 AM
Marinus Pharmaceuticals to Present at the Baird Healthcare ConferenceMarinus Pharmaceuticals to Present at the Baird Healthcare Conference
finance.yahoo.com - August 30 at 5:11 PM
Analysis: Positioning to Benefit within MannKind, Chimerix, Superior Energy Services, Marinus Pharmaceuticals, Airgain, and Eagle Pharmaceuticals — Research Highlights Growth, Revenue, and Consolidated ResultsAnalysis: Positioning to Benefit within MannKind, Chimerix, Superior Energy Services, Marinus Pharmaceuticals, Airgain, and Eagle Pharmaceuticals — Research Highlights Growth, Revenue, and Consolidated Results
finance.yahoo.com - August 28 at 8:25 AM
Marinus Pharmaceuticals to Present at Wedbush/PacGrow Healthcare ConferenceMarinus Pharmaceuticals to Present at Wedbush/PacGrow Healthcare Conference
finance.yahoo.com - August 7 at 8:32 AM
Heres Why Marinus Pharmaceuticals Inc. Fell as Much as 20.1% TodayHere's Why Marinus Pharmaceuticals Inc. Fell as Much as 20.1% Today
www.msn.com - August 2 at 5:22 PM
Marinus Pharmaceuticals: 2Q Earnings SnapshotMarinus Pharmaceuticals: 2Q Earnings Snapshot
finance.yahoo.com - August 2 at 5:22 PM
Here's Why Marinus Pharmaceuticals Inc. Fell as Much as 20.1% TodayHere's Why Marinus Pharmaceuticals Inc. Fell as Much as 20.1% Today
finance.yahoo.com - August 2 at 5:22 PM
Marinus Pharmaceuticals Provides Business Update and Second Quarter 2018 Financial ResultsMarinus Pharmaceuticals Provides Business Update and Second Quarter 2018 Financial Results
finance.yahoo.com - August 2 at 8:32 AM
Opinion: Harry Boxers four health-care stocks to watchOpinion: Harry Boxer's four health-care stocks to watch
www.marketwatch.com - July 12 at 4:42 PM
Cantor Fitzgerald Starts Marinus Pharmaceuticals (MRNS) at OverweightCantor Fitzgerald Starts Marinus Pharmaceuticals (MRNS) at Overweight
www.streetinsider.com - July 11 at 4:54 PM
Pfizer Doesnt Look Fundamentally or Technically StrongPfizer Doesn't Look Fundamentally or Technically Strong
finance.yahoo.com - July 11 at 4:54 PM
Marinus Pharma (MRNS) Commences Pivotal Phase 3 Trial in Children with CDKL5 Deficiency DisorderMarinus Pharma (MRNS) Commences Pivotal Phase 3 Trial in Children with CDKL5 Deficiency Disorder
www.streetinsider.com - June 22 at 9:16 AM
Marinus Pharmaceuticals to Be Added to the Russell 2000 and Russell 3000 IndexMarinus Pharmaceuticals to Be Added to the Russell 2000 and Russell 3000 Index
finance.yahoo.com - June 21 at 9:00 AM
Marinus Pharmaceuticals Initiates Pivotal Phase 3 Trial in Children with CDKL5 Deficiency DisorderMarinus Pharmaceuticals Initiates Pivotal Phase 3 Trial in Children with CDKL5 Deficiency Disorder
finance.yahoo.com - June 19 at 9:01 AM
Marinus Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(C)(4)Marinus Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(C)(4)
finance.yahoo.com - June 16 at 8:28 AM
Marinus Pharmaceuticals Has 3 Major Catalysts In 2018, Ladenburg Thalmann Says In Bullish InitiationMarinus Pharmaceuticals Has 3 Major Catalysts In 2018, Ladenburg Thalmann Says In Bullish Initiation
finance.yahoo.com - June 7 at 8:24 AM
Marinus Pharmaceuticals to Present at Upcoming Investor ConferencesMarinus Pharmaceuticals to Present at Upcoming Investor Conferences
feeds.benzinga.com - May 30 at 8:16 AM
Baird Starts Marinus Pharmaceuticals (MRNS) at OutperformBaird Starts Marinus Pharmaceuticals (MRNS) at Outperform
www.streetinsider.com - May 27 at 8:44 AM
This page was last updated on 12/12/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel